The stock dipped 11% to Rs 891, also its 52-week low on the BSE after the company reported a 96% year on year (yoy) decline in net profit at Rs 278 million in June 2018 quarter.
Leveraged bets worth over Rs 700 bn riding on the IPO; break up cost at Rs 1,500 versus issue price of Rs 1,100
The stock touched a high of Rs 725 and low of Rs 628 on NSE, where shares worth Rs 7.8 billion were traded
HDFC reported good operational performance for Q1, with assets under management growing 18 per cent year-on-year
Shares of Bank of Baroda gained 10.4 per cent, followed by State Bank of India and Punjab National Bank
A genuine demand recovery in the sector, experts say, is still some time away even as the prices continue to spiral down.
Nifty outlook and few trading ideas by Vaishali Parekh, Research Analyst - Technical Research at Prabhudas Lilladher
The original set of keys comes in handy during the insurance claim-settlement process
Nifty, Bank Nifty, Mahindra & Mahindra, Infosys and Hindustan Unilever
We will be very selective in our fund launches, depending on investor need and the right timing, says DSP BlackRock president Kalpen Parekh
After muted June-quarter performance due to cost and pricing pressure, the outlook for seasonally weak second quarter is no different
Most economists in a Bloomberg News survey expect the RBI to raise the report rate by 25 basis points on Aug 1
He has worked in Asian and Indian equity markets earlier, having held senior positions with several leading companies such as BNP Paribas Securities, Kotak Securities, HDFC Securities
Nifty outlook and top trading ideas by Jay Anand Thakkar, CMT -Assistant Vice President - Equity Research, Anand Rathi Research.
TCNS Clothing settled at Rs 665, down 7.1% against its issue price of Rs 716, after listing at par on the NSE.
Likening their performance and fundamentals to the pure technique of a test batsmen, IIFL Institutional Equities has ranked these six as its best choice for long-term investing
Among sectoral indices, the Nifty PSU Bank index settled over 4% higher led by a rise in Bank of Baroda, Andhra Bank and Oriental Bank of Commerce.
The stock hit a fresh 52-week low of Rs 511, down 3% on the BSE on Monday, extending its 5% decline in past three trading sessions in otherwise firm market on back of heavy volumes.
The stock surged 14% to Rs 36.20 on the NSE after the company received USFDA approval for both its bulk drugs manufacturing facilities situated in Himachal Pradesh.
Thus far in the calendar year 2018, Thyrocare had underperformed the market by falling 14% as compared to 8.6% rise in the S&P BSE Sensex till Friday.